Two separate studies in 1994 first described Kirsten rat sarcoma viral oncogene homolog (KRAS) and neuroblastoma RAS viral (v-ras) oncogene homolog (NRAS) mutations in the blood of pancreatic carcinoma [89] and leukemia patients [90]. Here, KRAS is linked to exocrine pancreatic carcinoma.